MedTrace Logo

Metformin Versus Vildagliptin for Diabetic Hypertensive Patients

NCT03253562 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-08-18

No results posted yet for this study

Summary

This is a controlled study to measure the efficacy of using metformin or vildagliptin for type 2 diabetic patients who suffers from hypertension to reduce cardiovascular risk resulting from both diabetes and hypertension using different parameters measuring

Conditions

  • Reducing the Elevated Blood Pressure for Diabetic Hypertensive Patients

Interventions

DRUG

Metformin Pill

a biguanide used as an insulin sensitizer for patients suffering from type 2 diabetes mellitus

DRUG

Vildagliptin 50 mg

Dpp4i antihyperglycemic drug used for treatment of type 2 diabetes mellitus

Sponsors & Collaborators

  • MTI University

    lead OTHER

Principal Investigators

  • Hekma A Abdel-Latif, Professor · cairo university faculty of pharmacy

  • Abdel Rahman M El-Naggar, Professor · Cairo University

  • Mohammed F Elyamany, assistant professor · cairo university faculty of pharmacy

  • Soha O Hassanin, lecturer · MTI unuversity faculty of pharmacy

  • Atef Bassyouni, Professor · National institute of diabetes and endocrinology

  • Dalia K Zaafar, assistant lecturer · MTI unuversity faculty of pharmacy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2017-08-01
Completion
2017-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03253562 on ClinicalTrials.gov